BIODESIGN
Rational Bioactive Materials Design for Tissue Regeneration
| Coordinatore | UPPSALA UNIVERSITET
Organization address
address: SANKT OLOFSGATAN 10 B contact info |
| Nazionalità Coordinatore | Sweden [SE] |
| Totale costo | 14˙795˙458 € |
| EC contributo | 10˙966˙966 € |
| Programma | FP7-NMP
Specific Programme "Cooperation": Nanosciences, Nanotechnologies, Materials and new Production Technologies |
| Code Call | FP7-NMP-2010-LARGE-4 |
| Funding Scheme | CP-IP |
| Anno di inizio | 2012 |
| Periodo (anno-mese-giorno) | 2012-01-01 - 2016-12-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
UPPSALA UNIVERSITET
Organization address
address: SANKT OLOFSGATAN 10 B contact info |
SE (UPPSALA) | coordinator | 2˙171˙206.00 |
| 2 |
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH
Organization address
address: Raemistrasse 101 contact info |
CH (ZUERICH) | participant | 825˙471.00 |
| 3 |
UNIVERSITY COLLEGE LONDON
Organization address
address: GOWER STREET contact info |
UK (LONDON) | participant | 741˙591.62 |
| 4 |
TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY
Organization address
address: TECHNION CITY - SENATE BUILDING contact info |
IL (HAIFA) | participant | 594˙796.00 |
| 5 |
REGENTIS BIOMATERIALS LTD
Organization address
address: HA ILAN STREET 2 NORTHERN INDUSTRIAL ZONE contact info |
IL (OR AKIVA) | participant | 584˙736.00 |
| 6 |
AO-FORSCHUNGSINSTITUT DAVOS
Organization address
address: Clavadelerstrasse 8 contact info |
CH (Davos Platz) | participant | 573˙042.00 |
| 7 |
UNIVERSITY OF SOUTHAMPTON
Organization address
address: Highfield contact info |
UK (SOUTHAMPTON) | participant | 546˙635.00 |
| 8 |
UNIVERSITY OF KEELE
Organization address
address: KEELE UNIVERSITY FINANCE DPT contact info |
UK (KEELE) | participant | 538˙211.00 |
| 9 |
KING'S COLLEGE LONDON
Organization address
address: Strand contact info |
UK (LONDON) | participant | 517˙790.00 |
| 10 |
Regentec Limited
Organization address
address: Pennyfoot Street BioCity contact info |
UK (Nottingham) | participant | 492˙344.00 |
| 11 |
THE UNIVERSITY OF NOTTINGHAM
Organization address
address: University Park contact info |
UK (NOTTINGHAM) | participant | 489˙857.00 |
| 12 |
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Organization address
address: BATIMENT CE 3316 STATION 1 contact info |
CH (LAUSANNE) | participant | 463˙274.00 |
| 13 |
LUDWIG BOLTZMANN GESELLSCHAFT OSTERREICHISCHE VEREINIGUNG ZUR FORDERUNG DER WISSENSCHAFTLICHEN FORSCHUNG
Organization address
address: NUSSDORFER STRASSE 64/6 contact info |
AT (WIEN) | participant | 445˙260.00 |
| 14 |
UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF
Organization address
address: Martinistrasse 52 contact info |
DE (HAMBURG) | participant | 435˙467.00 |
| 15 |
THE UNIVERSITY OF MANCHESTER
Organization address
address: OXFORD ROAD contact info |
UK (MANCHESTER) | participant | 380˙426.38 |
| 16 |
UNIVERSITY OF NOTTINGHAM IN MALAYSIA
Organization address
address: JALAN RAJA CHULAN (BOUSTEAM HOLDINGS) 69 contact info |
MY (KUALA LUMPUR) | participant | 353˙335.00 |
| 17 |
STRYKER TRAUMA GMBH
Organization address
address: PROF KUNTSCHER STRASSE 1-5 contact info |
DE (SCHONKIRCHEN) | participant | 243˙805.00 |
| 18 |
TRAUMA CARE CONSULT TRAUMATOLOGISCHE FORSCHUNG GEMEINNUTZIGE GMBH
Organization address
address: GONZAGAGASSE 11/25 contact info |
AT (WIEN) | participant | 222˙957.00 |
| 19 |
TERMIRA AB
Organization address
address: MALMGARDSVAGEN 32A contact info |
SE (STOCKHOLM) | participant | 191˙962.00 |
| 20 |
LALIT AB
Organization address
address: ANDERS REIMERS VAG 17 1TR contact info |
SE (STOCKHOLM) | participant | 104˙108.05 |
| 21 |
DANDO WEISS & COLUCCI LIMITED
Organization address
address: LOWER BRISTOL ROAD MINERVA HOUSE contact info |
UK (BATH) | participant | 50˙691.95 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The development of functional materials for tissue regeneration is today mostly based on perceived and limited design criteria often using a single point approach with lengthy animal trials. The outcome after in-vitro and in-vivo evaluation is often disappointing resulting in a tedious iteration process. The main objective of this project is to achieve radical innovations in state-of-the-art biomaterials and to design highly performing bioinspired materials learning from natural processes. By this outcome driven project comprising first class academic and industrial participants the project will create scientific and technical excellence and through links with these SMEs will strengthen the technological capacity and their ability to operate competitively on an international market. BIODESIGN will (i) perform a careful retrospective-analysis of previous outcomes from clinical studies performed with humans through animal modelling in a reverse engineering approach applied to an in-vitro to the molecular design level, (ii) develop new strategies for a more rational design of ECM mimetic materials serving both as gels and load carrying scaffolds, (iii) link novel designs to adequate and more predictive in-vitro methods allowing significant reduction in development time and use of animals and (iv) evaluate these concepts for musculoskeletal and cardiac regeneration. By the development of safe, ethically and regulatory acceptable, and clinically applicable materials this project will promote harmonization while at the same time creating awareness in society of the benefits of these innovations as one of the key points is to improve health and quality of life of the patients. BIODESIGN will stimulate technological innovation, utilization of research results, transfer of knowledge and technologies and creation of technology based business in Europe. It will also support the development of world-class human resources, making Europe a more attractive to top researchers.'